| Fecha | Hora | Fuente | Título | Símbolo | Compañía |
| 06/03/2013 | 15:57 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 14/02/2013 | 14:57 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 07/02/2013 | 15:29 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 05/02/2013 | 16:12 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 05/02/2013 | 16:10 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 05/02/2013 | 16:10 | Edgar (US Regulatory) | Definitive Materials Filed by Investment Companies. (497) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 05/02/2013 | 15:30 | GlobeNewswire Inc. | Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Actavis | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/02/2013 | 15:41 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/02/2013 | 15:32 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 28/01/2013 | 11:21 | Zacks | PTX Reduces Sales Force, CFO Quits - Analyst Blog | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 12:15 | Zacks | Pernix Acquires Cypress and Hawthorn - Analyst Blog | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 18:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 17:55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 21/12/2012 | 15:41 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 21/12/2012 | 15:35 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 21/12/2012 | 15:32 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 20/12/2012 | 15:53 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 20/12/2012 | 15:53 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 18/12/2012 | 11:19 | PR Newswire (US) | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Young Innovations, Inc. (YDNT), Compuware Corp. (CPWR), C... | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 17/12/2012 | 15:35 | GlobeNewswire Inc. | Somaxon Announces That Paladin Labs Has Received Approval of New Drug Submission for Silenor (R) in Canada | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 17/12/2012 | 11:59 | PR Newswire (US) | Lifshitz Law Firm Announces Investigation of Caribou Coffee Company, Inc., Epoch Holding Corporation, Somaxon Pharmaceuticals... | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 17/12/2012 | 10:55 | PR Newswire (US) | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Intermec Inc. (IN), Somaxon Pharmaceuticals, Inc. (SOMX),... | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 14/12/2012 | 16:11 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 13/12/2012 | 20:30 | PR Newswire (US) | Law Office of Brodsky & Smith, LLC Announces Investigation of Somaxon Pharmaceuticals, Inc. | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 12/12/2012 | 12:09 | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 12/12/2012 | 09:59 | PR Newswire (US) | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Plains Exploration & Production Company (PXP), Intermec I... | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 12/12/2012 | 08:41 | Business Wire | Somaxon Pharmaceuticals Investor Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Sale to Pernix Therapeutics | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 11/12/2012 | 09:31 | Business Wire | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Som... | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 11/12/2012 | 06:00 | GlobeNewswire Inc. | Pernix Therapeutics Announces Agreement to Acquire Somaxon Pharmaceuticals, Inc. | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 01/11/2012 | 05:07 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |